New England Journal of Medicine , 387(24), 2245-2257
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF GLP-1 Agonists Market by Product (Ozempic, Wegovy, Mounjaro), Molecule (semaglutide, tirzepatide), Type (Patented, Biosimilars), Format (Single dose, Multi-dose, Tablets), ROA (SC, Oral), Indication (Diabetes, Obesity) - Global Forecast to 2033 USD 170.75 BN MARKET SIZE, 2033 OVERVIEW Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global GLP-1 agonists market is expected to reach USD 170.75 billion in 2033 from USD 64.42 billion in 2025 at a CAGR of 13.0% during the forecast period
Per Trimi's published Refund Policy (last updated June 17, 2026): you need to stay on a continuous paid plan for six full months, take the medication as directed, log both a starting weight and a 6-month weight in the patient portal, and complete provider check-ins
They can be useful, but you are responsible for researching and asking questions